Chinese clinical stage biotech company InventisBio Inc has raised a $70-million Series C financing round co-led by venture capital firm Advantech Capital and CMB International Capital Corporation Limited (CMBI), an investment unit of China Merchants Bank, according to an official release.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
